Skip to main content
. 2023 Jan 10:1–14. Online ahead of print. doi: 10.1007/s11010-022-04657-0

Fig. 3.

Fig. 3

Treatment options for the monkeypox disease, and their underlying mechanisms of action. Brincidofovir and cidofovir stop the viral replication by inhibiting DNA polymerase enzyme. Tecovirimat on the other hand interferes with the viral envelope formation. Another antiviral drug NIOCH-14 is known to stop viral replication by serving as nucleoside